tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BioArctic and Eisai Advance Alzheimer’s Treatment with FDA Submission
PremiumCompany AnnouncementsBioArctic and Eisai Advance Alzheimer’s Treatment with FDA Submission
1M ago
FDA Approves BioArctic’s Subcutaneous Alzheimer’s Treatment
Premium
Company Announcements
FDA Approves BioArctic’s Subcutaneous Alzheimer’s Treatment
1M ago
BioArctic AB Sees Growth with Leqembi® and Novartis Partnership
Premium
Company Announcements
BioArctic AB Sees Growth with Leqembi® and Novartis Partnership
1M ago
BioArctic Reports Strong Q2 2025 Leqembi Sales Boost
PremiumCompany AnnouncementsBioArctic Reports Strong Q2 2025 Leqembi Sales Boost
2M ago
BioArctic’s Lecanemab Shows Promising Long-Term Benefits in Alzheimer’s Treatment
Premium
Company Announcements
BioArctic’s Lecanemab Shows Promising Long-Term Benefits in Alzheimer’s Treatment
2M ago
BioArctic and Eisai to Present Lecanemab Data at AAIC 2025
Premium
Company Announcements
BioArctic and Eisai to Present Lecanemab Data at AAIC 2025
3M ago
BioArctic AB Issues New Shares Under Stock Option Program
PremiumCompany AnnouncementsBioArctic AB Issues New Shares Under Stock Option Program
4M ago
BioArctic AB Annual General Meeting Resolutions and New Incentive Program
Premium
Company Announcements
BioArctic AB Annual General Meeting Resolutions and New Incentive Program
5M ago
BioArctic Gains EU Orphan Designation for MSA Treatment
Premium
Company Announcements
BioArctic Gains EU Orphan Designation for MSA Treatment
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100